Activin receptor-like kinase 7 mediates high glucose-induced H9c2 cardiomyoblast apoptosis through activation of Smad2/3

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 9, 2013, Pages 2027-2035

  Liu, Lin ^a   Ding, Wen Yuan ^a   Zhao, Jing ^a   Wang, Zhi Hao ^a   Zhong, Ming ^a   Zhang, Wei ^a   Chen, Yu Guo ^a   Zhang, Yun ^a   Li, Li ^a   Tang, Meng Xiong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Activin receptor like kinase 7; Apoptosis; Cardiomyocyte; Glucose; Smad2 3

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 7; CASPASE 3; PROTEIN BCL 2; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEART MUSCLE CELL; INHIBITION KINETICS; MYOBLAST; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

RATTUS;

ACTIVIN RECEPTOR-LIKE KINASE; ACTIVIN RECEPTOR-LIKE KINASE 7; ACTIVIN TYPE II RECEPTORS; ACTRII; ALK; APOPTOSIS; B-CELL LYMPHOMA-2; BCL-2; BMPS; BONE MORPHOGENETIC PROTEINS; CARDIOMYOCYTE; DCM; DIABETIC CARDIOMYOPATHY; DMEM; DULBECCO'S MODIFIED EAGLE'S MEDIUM; FBS; FETAL BOVINE SERUM; GDF; GLUCOSE; GROWTH AND DIFFERENTIATION FACTORS; SIRNA; SMAD2/3; SMALL INTERFERING RNA; TGF-Β; TRANSFORMING GROWTH FACTOR-Β; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; XIAP;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; APOPTOSIS; CELL LINE; DIABETIC CARDIOMYOPATHIES; GLUCOSE; MYOBLASTS, CARDIAC; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFECTION; UP-REGULATION;

EID: 84885143547     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.06.018     Document Type: Article

References (35)

1. Andersson O, Korach-Andre M, Reissmann E., Ibanez CF, Bertolino P. Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 2008; 105(20):7252-6. (Pubitemid 351754464)
2. Bakkebø M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, et al. SARA is dispensable for functional TGF-β signaling. FEBS Letters 2012; 586(19):3367-72.
3. Bertolino P, Holmberg R, Reissmann E., Andersson O, Berggren PO, Ibanez CF Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proceedings of the National Academy of Sciences of the United States of America 2008; 105(20):7246-51. (Pubitemid 351754463)
4. Bondestam J, Huotari MA, Morén A, Ustinov J., Kaivo-Oja N, Kallio J, et al cDNA cloning, expression studies and chromosomemapping of human type I serine/threonine kinase receptor ALK7 (ACVR1C). Cytogenetics and Cell Genetics 2001; 95:157-62. (Pubitemid 34638952)
5. Castoldi G, di Gioia CR, Bombardi C, Perego C, Perego L., Mancini M, et al Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. Clinical Science (London) 2009; 118(3):211-20.
6. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty T.K., et al Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000; 101(19):2271-6. (Pubitemid 30317129)
7. Falcao-Pires I., Leite-Moreira AF. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Failure Reviews 2012; 17(3):325-44.
8. Foo RS, Mani K, Kitsis RN. Death begets failure in the heart. Journal of Clinical Investigation 2005; 115(3):565-71. (Pubitemid 40322226)
9. Greenwald J, Groppe J, Gray P., Wiater E, Kwiatkowski W, Vale W., et al The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Molecular Cell 2003; 11(3):605-17. (Pubitemid 36385117)
10. Hao HH, Lu Q, Tang D.Q., Shao ZM, Yin XX, Mou J, et al Protective effects of quercetin on streptozotocin-induced diabetic nephropathy in rats. Phytotherapy Research 2012; 27 [Epub ahead of print].
11. Heger J, Warga B, Meyering B., Abdallah Y, Schlüter KD, Piper H.M., et al TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release. Journal of Cellular Physiology 2011; 226(10):2683-90.
12. Heger J, Peters SC, Piper H.M., Euler G. SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes. Journal of Cellular Physiology 2009; 220(2):515-23.
13. Kido S, Kuriwaka-Kido R, Umino-Miyatani Y, Endo I, Inoue D., Taniguchi H, et al Mechanical stress activates Smad pathway through PKCδ to enhance interleukin-11 gene transcription in osteoblasts. PLoS ONE 2010; 5(9)., http://dx.doi.org/10.1371/journal.pone.0013090, pii: e1309.
14. Kuethe F, Sigusch HH, Bornstein S.R., Hilbig K., Kamvissi V, Figulla HR Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? Hormone and Metabolic Research 2007; 39(9):672-6. (Pubitemid 47492651)
15. Kim BC, van Gelder H, Kim TA, Lee H.J., Baik KG, Chun HH, et al Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells. Journal of Biological Chemistry 2004; 279(27):28458-65. (Pubitemid 38900127)
16. Liu JE, Palmieri V, Roman M.J., Bella JN, Fabsitz R, Howard BV, et al The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the strong heart study. Journal of the American College of Cardiology 2001; 37(7):1943-9. (Pubitemid 32499984)
17. Lorentzon M, Hoffer B, Ebendal T., Olson L, Tomac A. Habrec1 a novel serine/threonine kinase TGF-beta type I-like receptor, has a specific cellular expression suggesting function in the developing organism and adult brain. Experimental Neurology 1996; 142:351-60. (Pubitemid 26414067)
18. Mungrue IN, Zhao P, Yao Y., Meng H, Rau C, Havel J.V., et al Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model. Arteriosclerosis, Thrombosis, and Vascular Biology 2011; 31(12):2806-12.
19. Massagué J, Gomis RR. The logic of TGF-beta signaling. FEBS Letters 2006; 580(12):2811-20.
20. Massagué J, Chen Y-G. Controlling TGF-beta signaling. Genes and Development 2000; 6:627-44.
21. Narayan S, Thangasamy T, Balusu R. Transforming growth factor-beta receptor signaling in cancer. Frontiers in Bioscience 2005; 10:1135-45.
22. Pfister R, Erdmann E. Diabetes mellitus and heart failure: epidemiology and therapy. Herz 2008; 33(3):178-83. (Pubitemid 351581151)
23. Roberts HJ, Hu S, Qiu Q., Leung PC, Caniggia I, Gruslin A, et al Identification of novel isoforms of activin receptor-like kinase 7 (ALK7) generated by alternative splicing and expression of ALK7 and its ligand, nodal, in human placenta. Biology of Reproduction 2003; 68(5):1719-26. (Pubitemid 36519777)
24. Reissmann E, Jörnvall H, Blokzijl A., Andersson O, Chang C, Minchiotti G., et al The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by nodal proteins during vertebrate development. Genes and Development 2001; 15(15):2010-22. (Pubitemid 32738629)
25. Rydén M., Imamura T, Jornvall H., Belluardo N, Neveu I, Trupp M., et al A novel type I receptor serine/threonine kinase predominantly expressed in the adult central nervous system. Journal of Biological Chemistry 1996; 271(48): 30603-9. (Pubitemid 26404073)
26. Shaw JE, Sicree RA, Zimmet PZ Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010; 87(1): 4-14.
27. Shen JJ, Huang L, Li L., Jorgez C, Matzuk MM, Brown CW Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose. Molecular Endocrinology 2009; 23(1):113-23.
28. Schroder D, Heger J, Piper H.M., Euler G. Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. Journal of Molecular Medicine (Berlin) 2006; 84(11):975-83. (Pubitemid 44655875)
29. Schneiders D, Heger J, Best P, Michael Piper H, Taimor G. SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes. Cardiovascular Research 2005; 67(1):87-96. (Pubitemid 40798295)
30. Tsuchida K, Nakatani M, Uezumi A., Murakami T, Cui X. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer. Endocrine Journal 2008; 55(1):11-21. (Pubitemid 351520175)
31. Tsuchida K, Sawchenko PE, Nishikawa S.I., Vale WW Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF-hsuperfamily from rat brain. Molecular and Cellular Neuroscience 1996; 7(6):467-78. (Pubitemid 26300333)
32. Wang H, Jiang JY, Zhu C, Peng C., Tsang BK Role and regulation of nodal/activin receptor-like kinase 7 signaling pathway in the control of ovarian follicular atresia. Molecular Endocrinology 2006; 20(10):2469-82. (Pubitemid 44496415)
33. Xu G, Zhou H, Wang Q., Auersperg N, Peng C. Activin receptor-like kinase 7 induces apoptosis through up-regulation of bax and down-regulation of xiap in normal and malignant ovarian epithelial cell lines. Molecular Cancer Research 2006; 4(4):235-46.
34. Zhao F, Huang F, Tang M., Li X, Zhang N, Amfilochiadis A., et al Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 β-cells. American Journal of Physiology: Endocrinology and Metabolism 2012; 303(1):132-43.
35. Zhang N, Kumar M, Xu G., Ju W, Yoon T, Xu E., et al Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines. Diabetologia 2006; 49(3):506-18. (Pubitemid 43277874)